Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
205.33
+3.43 (1.70%)
Mar 9, 2026, 1:37 PM EDT - Market open
Ligand Pharmaceuticals Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$245.17
Upside
+19.40%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $275 → $277 | Buy | Maintains | $275 → $277 | +34.90% | Feb 27, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $231 → $239 | Strong Buy | Maintains | $231 → $239 | +16.40% | Feb 24, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $234 → $235 | Buy | Maintains | $234 → $235 | +14.45% | Dec 10, 2025 |
| Stifel | Stifel | Strong Buy Maintains $220 → $230 | Strong Buy | Maintains | $220 → $230 | +12.01% | Dec 10, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $270 | Strong Buy | Initiates | $270 | +31.50% | Dec 9, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $185 → $234 | Buy | Maintains | $185 → $234 | +13.96% | Nov 10, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $250 → $275 | Buy | Maintains | $250 → $275 | +33.93% | Nov 7, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $175 → $220 | Strong Buy | Maintains | $175 → $220 | +7.14% | Nov 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $206 → $231 | Strong Buy | Maintains | $206 → $231 | +12.50% | Nov 6, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $190 → $250 | Buy | Maintains | $190 → $250 | +21.76% | Nov 3, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $167 → $190 | Buy | Maintains | $167 → $190 | -7.47% | Sep 3, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $160 → $175 | Strong Buy | Maintains | $160 → $175 | -14.77% | Sep 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $157 → $206 | Strong Buy | Maintains | $157 → $206 | +0.33% | Aug 28, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $155 → $185 | Buy | Maintains | $155 → $185 | -9.90% | Aug 8, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $162 → $167 | Buy | Maintains | $162 → $167 | -18.67% | Aug 7, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $145 → $162 | Buy | Maintains | $145 → $162 | -21.10% | Jul 30, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.